Stocklytics Platform
Asset logo for symbol MRK
Merck & Co
MRK69
$77.69arrow_drop_down0.28%-$0.22
S&P500
Asset logo for symbol MRK
MRK69

$77.69

arrow_drop_down0.28%
no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Fundamentals
Industry average yield2.89%
Last Dividend pay dateApr 7, 2025

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

MRK-
US Healthcare Sector-
US Market-
warning

MRK / Market

MRK lose to the US Market which returned 0.03% over the last twenty four hours.
warning

MRK / Healthcare Sector

MRK lose to the US Healthcare sector which returned 2.60% over the last twenty four hours.

Merck & Co (MRK) Statistics

Merck & Co Inc, commonly known as Merck, is a global pharmaceutical company that specializes in discovering, developing, manufacturing, and marketing a wide range of innovative medical solutions. As of the latest statistics, the stock ticker for Merck is MRK. When evaluating the valuation metrics of Merck & Co Inc, various factors come into play. These include the company's market capitalization, price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio. These metrics help investors assess the relative value of MRK stock in comparison to its earnings, sales, and book value. Furthermore, analyzing the fundamentals of Merck & Co Inc is essential in understanding its financial health and stability. Key fundamental factors to consider include revenue growth, earnings growth, dividend yield, and return on equity.
When comparing the stock performance of Merck & Co Inc (MRK) against its sector, investors can gain insights into how well the company has fared relative to its industry peers. This comparison can be made by analyzing the stock's price performance, total return, and volatility against the sector average. Additionally, revenue per share is an important metric for investors to understand how much revenue Merck generates on a per-share basis. This metric provides a clearer picture of the company's financial performance and efficiency. In terms of enterprise to EBITDA, this ratio helps measure the company's ability to generate operating income in relation to its enterprise value. A higher ratio typically indicates better financial strength and profitability for Merck & Co Inc.
add Merck & Co  to watchlist

Keep an eye on Merck & Co

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the EBITDA of Merck & Co (MRK) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Merck & Co (MRK) is $26.23B. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How has Merck & Co (MRK) stock's performance compared to its sector and the market over the past year?

Over the past year, Merck & Co (MRK) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 15.12%, Merck & Co has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 23.87%, it has fallen short of the market average. This comparison highlights Merck & Co 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Merck & Co (MRK) stock?

The PE (Price to Earnings) ratio of Merck & Co (MRK) is currently 11.53. This metric is used to evaluate the valuation of a company's stock, comparing its current share price relative to its per-share earnings.
help

What is the EPS of Merck & Co (MRK) stock?

The Earnings Per Share (EPS) for Merck & Co (MRK), calculated on a diluted basis, is $6.74. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Merck & Co (MRK) stock?

The operating margin for Merck & Co (MRK) is 34.19%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

How much debt does Merck & Co (MRK) have?

Merck & Co (MRK) has a total debt of $38.27B. The net debt, which accounts for cash and cash equivalents against the total debt, is $23.87B.

Take Your Investments to a Whole New Level